Aptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a report issued on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 price target on shares of Aptose Biosciences in a report on Wednesday, February […]
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a report issued on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 price target on shares of Aptose Biosciences in a report on Wednesday, February […]
